2011 annual financial data
Cellectar Biosciences 2011 Operating margin
Direct answer
Operating margin was 63,979.27%.
Operating income was -7,037,720 USD and net income was -7,435,422 USD.
Operating cash flow was -5,970,090 USD.
Get free Cellectar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -11,000 USD
- Operating income
- -7,037,720 USD
- Net income
- -7,435,422 USD
- Operating cash flow
- -5,970,090 USD